Related Experiment Video
Updated: Aug 2, 2025

Author Spotlight: Detection and Treatment of Helicobacter pylori Infection
Published on: July 28, 2023
CORRELATION OF SOME IMMUNOLOGICAL MARKERS WITH HELICOBACTER PYLORI IN PATIENTS IN THI-QAR PROVINCE
1AL-NASIRIYA TECHNICAL INSTITUTE, AL-NASIRIYA, IRAQ.
Objective:
The aim: This study aims to investigate some of the immunological parameters related to Helicobacter pylori patients, including: interleukin (IL-17), cluster of differentiation 4 (CD4), macrophage inhibitory migration factor (MIF), nuclear factor kappa B (NF-kB).
Patients And Methods:
Materials and methods: The immunological parameters were investigated by using ELISA technology, and compared with the healthy individuals (control).
Results:
Results: The level of IL-17A in the serum showed a significant increase (p < 0.05) in the HPP group compared to the control group. The CD4 serum concentration in infected with H. pylori patients was high level (4.23 ± 0.41 ng/ml) with significant increase (p < 0.05) than to healthy individuals (control) (1.93 ± 0.22 ng/ml). Also, there was significant elevation (p < 0.05) in in the level of serum MIF levels in H. pylori patients (75.23 ± 1.88 ng/ml) as compared to the control (65.11 ± 2.25 ng/ml). Serum NF-kB concentration in patients infected with H. pylori was at a high level (8.15 ± 0.58 ng/ml) with a significant elevated (p < 0.05) as compared to control (3.91 ± 0.47 ng/ml). On the other hand, the results proved that there is significant elevation (p < 0.05) in blood NF-kB level in smokers infected with H. pylori (9.43 ± 0.95ng/ml), compared with non-smokers infected with Helicobacter pylori (4.96 ± 1.46 ng/ml).
Conclusion:
Conclusions: Both humoral and cellular immune response plays an important role in patients with Helicobacter pylori. The nuclear factor kappa B is considered a risk factor in smoking patients, infected with Helicobacter Pylori can be considered as an early diagnosis of stomach cancer.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease III: Clinical Manifestations and Diagnostic Studies
Few clinical manifestations differentiate gastric ulcers from duodenal ulcers. Distinctions in the location, timing, and pain relief are crucial for healthcare providers in differentiating between gastric and duodenal ulcers during clinical assessments.
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Gastritis III: Clinical Manifestations and Management
Clinical manifestations of acute gastritis
The patient with acute gastritis may have a rapid onset of symptoms, such as epigastric pain or discomfort, dyspepsia, anorexia, hiccups, or nausea and vomiting, which can last from a few hours to a few days. Erosive or hemorrhagic gastritis may cause bleeding, which may manifest as blood in vomit or as...

